Better Medicines for Children, A DIA/EFGCP Conference

Plan ahead and join us to reflect on the importance of two major headways that are currently affecting Paediatric research: Innovative approaches to Drug Development and impact of the current environment on the Regulatory and Research Infrastructure

Back to Agenda

Session 7: Orphan Medicines – Doing Studies in Small Populations

Session Chair(s)

To Be Announced

, NA, Switzerland

Geneviève Le Visage, PharmD, MSc

Head EU RA Policy and Liaison, Novartis Pharma AG, Switzerland

Session 7: Orphan Medicines – Doing Studies in Small Populations

Speaker(s)

Fabio D’Atri

Policy Officer, Deputy Head of Unit, Unit B5 Directorate General for Health and Food Safey, European Commission , Belgium

Feedback on the Joint Review of the Paediatric and Orphan Regulations

Thomas Kühler, PhD, MSc

Head GRSP EU/AMEE, Sanofi R&D, France

Orphan Medicines for Paediatric Use - A focus on the European Union

Have an account?

Better Medicines for Children, A DIA/EFGCP Conference

Session 7: Orphan Medicines – Doing Studies in Small Populations

Session Chair(s)

To Be Announced

Geneviève Le Visage, PharmD, MSc

Speaker(s)

Fabio D’Atri

Thomas Kühler, PhD, MSc

Be informed and stay engaged.